Oncotarget

Research Papers:

Differential response to exercise in claudin-low breast cancer

Oliver K. Glass, Michelle Bowie, Julie Fuller, David Darr, Jerry U sary, Keara Boss, Kingshuk Roy Choudhury, Xioajing Liu, Zoe Zhang, Jason W. Locasale, Christina Williams, Mark W. Dewhirst, Lee W. Jones _ and Victoria Seewaldt

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:100989-101004. https://doi.org/10.18632/oncotarget.21054

Metrics: PDF 943 views  |   HTML 2021 views  |   ?  


Abstract

Oliver K. Glass1, Michelle Bowie1, Julie Fuller1, David Darr2, Jerry Usary3, Keara Boss4, Kingshuk Roy Choudhury1, Xioajing Liu1, Zoe Zhang1, Jason W. Locasale1, Christina Williams1, Mark W. Dewhirst1,*, Lee W. Jones5,6,* and Victoria Seewaldt7,*

1 Duke University Medical Center, Durham, NC, USA

2 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

3 Arrow Genomics LLC, Chapel Hill, NC, USA

4 North Carolina State University, Raleigh, NC, USA

5 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

6 Weill Cornell Medical College, New York, NY, USA

7 City of Hope Cancer Center, Duarte, CA, USA

* These authors have contributed equally to this work

Correspondence to:

Lee W. Jones, email:

Mark W. Dewhirst, email:

Keywords: exercise, breast cancer, Hif1-α, mouse model, claudin-low

Received: July 18, 2017 Accepted: August 23, 2017 Published: September 19, 2017

Abstract

Exposure to exercise following a breast cancer diagnosis is associated with reductions in the risk of recurrence. However, it is not known whether breast cancers within the same molecular-intrinsic subtype respond differently to exercise. Syngeneic mouse models of claudin-low breast cancer (i.e., EO771, 4TO7, and C3(1)SV40Tag-p16-luc) were allocated to a uniform endurance exercise treatment dose (forced treadmill exercise) or sham-exercise (stationary treadmill). Compared to sham-controls, endurance exercise treatment differentially affected tumor growth rate: 1- slowed (EO771), 2- accelerated (C3(1)SV40Tag-p16-luc), or 3- was not affected (4TO7). Differential sensitivity of the three tumor lines to exercise was paralleled by effects on intratumoral Ki-67, Hif1-α, and metabolic programming. Inhibition of Hif1-α synthesis by the cardiac glycoside, digoxin, completely abrogated exercise-accelerated tumor growth in C3(1)SV40Tag-p16-luc. These results suggest that intratumoral Hif1-α expression is an important determinant of claudin-low breast cancer adaptation to exercise treatment.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 21054